Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia

Journal of Ovarian Research(2021)10.1186/s13048-021-00872-3Source: DataRank Database

Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia is a research paper published in Journal of Ovarian Research (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.49)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Shailesh Singh ORCID,Rajesh Singh ORCID,Santosh Kumar Singh ORCID

Live enrichment

PubMed:34579761 PMC:PMC8474883 OpenAlex:https://openalex.org/W3204744278

national institutes of health

Grant: SC1CA193758

national cancer institute

Grant: U54CA118638

dod prostate cancer research program

Grant: W81XWH-18-10429

National Institutes of Health

Grant: 5SC1CA193758-04

Targeted Nanotherapy for prostate cancer

National Institutes of Health

Grant: 2U54CA118638-02

Cancer Education Program

FWCI

1.49

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://ovarianresearch.biomedcentral.com/counter/pdf/10.1186/s13048-021-00872-3

publisherhttps://ovarianresearch.biomedcentral.com/counter/pdf/10.1186/s13048-021-00872-3

publisherhttps://link.springer.com/content/pdf/10.1186/s13048-021-00872-3.pdf

publisherhttps://link.springer.com/article/10.1186/s13048-021-00872-3/fulltext.html

journalhttps://doi.org/10.1186/s13048-021-00872-3

Fields of Study

Natural Antidiabetic Agents StudiesBiochemical and Structural CharacterizationTransgenic Plants and Applications0301 basic medicine03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentBinding SitesHumansOleanolic AcidPlant ExtractsProtein BindingSurface Plasmon ResonanceMomordica charantiaHydrophobic and Hydrophilic InteractionsMolecular Docking SimulationSpike Glycoprotein, Coronavirus

Keywords

MomordicaDocking (animal)In silicoLipinski's rule of fiveSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineCoronavirus disease 2019 (COVID-19)BiochemistryChemistryTraditional medicineVeterinary medicineInfectious disease (medical specialty)Momordica charantiaSPRbitter melonErythrodiolSars-cov-2Binding SitesPlant ExtractsResearchCOVID-19Gynecology and obstetricsSurface Plasmon ResonanceCOVID-19 Drug TreatmentMolecular Docking SimulationSpike Glycoprotein, CoronavirusRG1-991HumansOleanolic AcidHydrophobic and Hydrophilic InteractionsProtein Binding

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia

FAIR Checklist

Authors (3)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)